You are here: Industry Insights > COVID-19

News List

LumiraDx Lab Analysis Confirms its COVID-19 Antigen Test Detects the Omicron Variant prnasia
January 17, 2022
LumiraDx (Nasdaq: LMDX), a next-generation point of care diagnostics company, today announced that results from ongoing testing and monitoring of COVID-19 variants show its SARS-CoV-2 Antigen test detects the Omicron Variant.
Vivera Pharmaceuticals Issues Statement Regarding LuSys Laboratories COVID-19 Tests prnewswire
January 17, 2022
Vivera Pharmaceuticals is highly discouraged to read the latest FDA safety communication that erroneously lists Vivera Pharmaceuticals as a brand of LuSys Laboratories or as a distributor of the LuSys Eagle Diagnostics test.
COVAX delivers its 1 billionth COVID-19 vaccine dose FirstWordPharma
January 17, 2022
A shipment of 1.1 million COVID-19 vaccines to Rwanda included the billionth dose supplied via COVAX.
Peru urges vaccine sellers to extend expiration dates to cut risk of losses FirstWordPharma
January 17, 2022
Peru’s Health Minister Hernando Cevallos asked companies to extend expiration dates past the current three months to reduce the risk of losing COVID-19 vaccine doses, as reported in National Post.
Bharat Biotech seeks full marketing approval from DCGI for Covaxin ExpressPharma
January 17, 2022
The company, however, is yet to submit the full follow up data of clinical trial of Covaxin to DCGI, a source said.
COVID Cases Surge Again in U.S. Nursing Homes drugs.com
January 17, 2022
Residents of nursing homes have been a particularly at-risk group throughout the pandemic, and the advent of the fast-spreading...
Insurance Often Covers Ivermectin for COVID-19, Even Though Drug Doesn't Work drugs.com
January 17, 2022
U.S. insurers are paying millions of dollars a year to cover the cost of ivermectin for COVID-19 patients despite a lack of proof the anti-parasitic drug is effective against the virus, a new study finds.
CDI prevention reaches date with destiny pharmatimes
January 17, 2022
Clinical stage outfit, Destiny Pharma, provides a positive summary of the year ahead
Everest Medicines, Singapore's EDDC Enter Global Licensing Agreement for COVID Oral Antivirals contractpharma
January 17, 2022
Everest gains exclusive global rights to a series of 3CL protease inhibitors to treat COVID-19.
While Omicron continues to dominate across the world, COVID-19 travel requirements remain pharmatimes
January 15, 2022
The scandal surrounding Novak Djokovic’s entry into Australia, following his vaccine exemption, has sparked outcry on both a national and global scale.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 437 438 Next page